Stephen Joseph Balevic | Scholars@Duke

Stephen Joseph Balevic
Assistant Professor of Pediatrics

I am an Adult and Pediatric Rheumatologist and care for patients with a wide variety of autoimmune and rheumatic diseases, including: systemic lupus, rheumatoid arthritis, juvenile arthritis, vasculitis, and sarcoidosis, among others. I have a special interest in using musculoskeletal ultrasound to optimize diagnosis and treatment decisions at the bedside.

I am also a clinical researcher at the Duke Clinical Research Institute (DCRI). My research interests are in clinical trials and precision medicine through population pharmacokinetic/pharmacodynamic modeling. I completed my clinical and research fellowships as well as a Master of Health Science Degree in Clinical Research at Duke University. I completed clinical pharmacology training though the NICHD sponsored, UNC-Duke Clinical Pharmacology T32 Training Program. I serve as the principal investigator on several foundation grants studying hydroxychloroquine and azathioprine pharmacokinetics and exposure-response in lupus, as well as principal investigator or co-investigator for several clinical trials at the DCRI.

Current Appointments & Affiliations

Assistant Professor of Pediatrics, Pediatrics, Rheumatology, Pediatrics 2021
Assistant Professor of Medicine, Medicine, Rheumatology and Immunology, Medicine 2020
Member of the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2018

Contact Information

stephen.balevic@duke.edu

Background
Education, Training, & Certifications
- Clinical Research Fellow, Dcri, Duke University School of Medicine 2016 - 2018
- Clinical Pharmacology Fellowship, Duke And Unc School Of Pharmacy, Duke University School of Medicine 2016 - 2018
- Fellowship Adult and Pediatric, Pediatrics, Duke University School of Medicine 2014 - 2018
- Internal Medicine and Pediatric Residency, Medical University of South Carolina, School of Medicine 2010 - 2014
- M.D., Marshall University 2010
Duke Appointment History
- Assistant Professor of Pediatrics, Pediatrics, Rheumatology, Pediatrics 2018 - 2020
- Assistant Professor of Medicine, Medicine, Rheumatology and Immunology, Medicine 2018 - 2020
Recognition
In the News
- SEP 22, 2020 DCRI Pulse
  
  DCRI Launches First Direct-to-Family Study
Research
Selected Grants
- Optimal Dosing for Biologic Agents in Obese Patients with Rheumatoid and Juvenile Arthritis awarded by National Institutes of Health 2020 - 2025
- Optimizing Hydroxychloroquine to Reduce Disease Activity in Pediatric Lupus awarded by Thrasher Research Fund 2021 - 2022
- PTN2- TO# BPCA Pharmacology Studies awarded by National Institute for Child Health & Human Develo 2018 - 2022
- Global Pediatric Clinical Trials Network awarded by Food and Drug Administration 2017 - 2022
- RTOP 18-0006 Option 1 / Protocol Implementation awarded by National Institute of Allergy and Infectious Diseases 2019 - 2022
- Vamorolone in Juvenile Autoimmune Myositis awarded by Cure JM Foundation 2020 - 2021
- RTOP 18-0006 Option 1 / Protocol Implementation awarded by National Institute of Allergy and Infectious Diseases 2019 - 2021
- HCQ Pharmacokinetics in Pediatric Lupus awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. 2019 - 2020
- PTN2- TO# Data Closeout and Dissemination awarded by National Institute for Child Health & Human Develo 2018 - 2019
- ACR/Amgen Rheumatology Fellowship Training Award awarded by Rheumatology Research Foundation 2015 - 2016
External Relationships
- The Childhood Arthritis and Rheumatology Research Alliance (CARRA)
- US Food and Drug Administration
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Balmuri, N., W. D. Soulsby, V. Cooley, L. Gerber, E. Lawson, S. Goodman, K. Onel, et al. “Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis (Accepted).” Pediatric Rheumatology 19, no. 1 (December 1, 2021). https://doi.org/10.1186/s12969-021-00610-5.
    Full Text
  - Beukelman, Timothy, Aimee Lougee, Roland A. Matsouaka, David Collier, Dax G. Rumsey, Jennifer Schenfeld, Scott Stryker, Marinka Twilt, Yukiko Kimura, and Yukiko CARRA Registry Investigators. “Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.” Pediatr Rheumatol Online J 19, no. 1 (August 21, 2021): 131. https://doi.org/10.1186/s12969-021-00625-y.
    Full Text Link to Item
  - Mannion, Melissa L., Fenglong Xie, Daniel B. Horton, Sarah Ringold, Colleen K. Correll, Anne Dennos, Timothy Beukelman, and Timothy CARRA Registry Investigators. “Biologic Switching Among Nonsystemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry.” J Rheumatol 48, no. 8 (August 2021): 1322–29. https://doi.org/10.3899/jrheum.200437.
    Full Text Link to Item
  - Lane, Morgan D., Sujata Kishnani, Obianuju Udemadu, Samuel Eshun Danquah, Robert M. Treadway, Aaliyah Langman, Stephen Balevic, et al. “Comparative efficacy and safety of late surfactant preparations: a retrospective study.” J Perinatol, July 20, 2021. https://doi.org/10.1038/s41372-021-01142-2.
    Full Text Link to Item
  - Rumsey, Dax G., Aimee Lougee, Roland Matsouaka, David H. Collier, Laura E. Schanberg, Jennifer Schenfeld, Natalie J. Shiff, et al. “Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in Sacroiliitis.” Arthritis Care Res (Hoboken) 73, no. 7 (July 2021): 940–46. https://doi.org/10.1002/acr.24537.
    Full Text Link to Item
  - Ong, Mei Sing, Sarah Ringold, Yukiko Kimura, Laura E. Schanberg, George A. Tomlinson, Marc D. Natter, and Marc D. and the CARRA Registry Investigators. “Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study.” Arthritis Rheumatol, June 8, 2021. https://doi.org/10.1002/art.41892.
    Full Text Link to Item
  - Randell, Rachel L., Lindsay Singler, Anthony Cunningham, Laura E. Schanberg, Michael Cohen-Wolkowiez, Christoph P. Hornik, Stephen J. Balevic, and Stephen J. with the CARRA Registry investigators. “Delivering clinical trials at home: protocol, design and implementation of a direct-to-family paediatric lupus trial.” Lupus Sci Med 8, no. 1 (May 2021). https://doi.org/10.1136/lupus-2021-000494.
    Full Text Link to Item
  - Rajendran, Aardra, Amanda M. Eudy, Stephen J. Balevic, and Megan E. B. Clowse. “The importance of pregnancy planning in lupus pregnancies.” Lupus 30, no. 5 (April 2021): 741–51. https://doi.org/10.1177/0961203321989803.
    Full Text Link to Item
  - Balevic, Stephen J., Lindsay Singler, Rachel Randell, Richard J. Chung, Monica E. Lemmon, and Christoph P. Hornik. “Bringing research directly to families in the era of COVID-19.” Pediatr Res 89, no. 3 (February 2021): 404–6. https://doi.org/10.1038/s41390-020-01260-1.
    Full Text Link to Item
  - Udupa, Akrithi, David Leverenz, Stephen J. Balevic, Rebecca E. Sadun, Teresa K. Tarrant, and Jennifer L. Rogers. “Hydroxychloroquine and COVID-19: a Rheumatologist's Take on the Lessons Learned.” Curr Allergy Asthma Rep 21, no. 1 (January 21, 2021): 5. https://doi.org/10.1007/s11882-020-00983-9.
    Full Text Link to Item
  - Balevic, Stephen J., Christoph P. Hornik, Thomas P. Green, Megan E. B. Clowse, Daniel Gonzalez, Anil R. Maharaj, Laura E. Schanberg, et al. “Dr. Balevic, et al reply.” J Rheumatol 47, no. 10 (October 1, 2020): 1587. https://doi.org/10.3899/jrheum.200681.
    Full Text Link to Item
  - Maharaj, Anil R., Huali Wu, Christoph P. Hornik, Stephen J. Balevic, Chi D. Hornik, P Brian Smith, Daniel Gonzalez, et al. “Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019.” Jama Pediatr 174, no. 10 (October 1, 2020): e202422. https://doi.org/10.1001/jamapediatrics.2020.2422.
    Full Text Link to Item
  - Balevic, Stephen J., Christoph P. Hornik, Thomas P. Green, Megan E. B. Clowse, Daniel Gonzalez, Anil R. Maharaj, Laura E. Schanberg, et al. “Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials.” J Rheumatol, May 11, 2020. https://doi.org/10.3899/jrheum.200493.
    Full Text Link to Item
  - Dallefeld, S. H., P. B. Smith, E. G. Crenshaw, K. R. Daniel, M. L. Gilleskie, D. S. Smith, S. Balevic, et al. “Comparative safety profile of chloral hydrate versus other sedatives for procedural sedation in hospitalized infants.” J Neonatal Perinatal Med 13, no. 2 (2020): 159–65. https://doi.org/10.3233/NPM-190214.
    Full Text Link to Item
  - Thompson, Elizabeth J., Huali Wu, Chiara Melloni, Stephen Balevic, Janice E. Sullivan, Matthew Laughon, Kira M. Clark, et al. “Population Pharmacokinetics of Doxycycline in Children.” Antimicrob Agents Chemother, September 23, 2019. https://doi.org/10.1128/AAC.01508-19.
    Full Text Link to Item
  - Balevic, Stephen J., P Brian Smith, Daniela Testoni, Huali Wu, Kim L. R. Brouwer, Kanecia O. Zimmerman, Nazario D. Rivera-Chaparro, Daniel K. Benjamin, and Michael Cohen-Wolkowiez. “Cefazolin pharmacokinetics in premature infants.” J Perinatol 39, no. 9 (September 2019): 1213–18. https://doi.org/10.1038/s41372-019-0368-z.
    Full Text Link to Item
  - Thompson, Elizabeth J., Huali Wu, Anil Maharaj, Andrea N. Edginton, Stephen J. Balevic, Marjan Cobbaert, Anthony P. Cunningham, Christoph P. Hornik, and Michael Cohen-Wolkowiez. “Physiologically Based Pharmacokinetic Modeling for Trimethoprim and Sulfamethoxazole in Children.” Clin Pharmacokinet 58, no. 7 (July 2019): 887–98. https://doi.org/10.1007/s40262-018-00733-1.
    Full Text Link to Item
  - Watt, Kevin M., Christoph P. Hornik, Stephen J. Balevic, Gratias Mundakel, C Michael Cotten, Barrie Harper, Daniel K. Benjamin, et al. “Pharmacokinetics of ticarcillin-clavulanate in premature infants.” Br J Clin Pharmacol 85, no. 5 (May 2019): 1021–27. https://doi.org/10.1111/bcp.13882.
    Full Text Link to Item
  - Balevic, Stephen J., Thomas P. Green, Megan E. B. Clowse, Amanda M. Eudy, Laura E. Schanberg, and Michael Cohen-Wolkowiez. “Pharmacokinetics of Hydroxychloroquine in Pregnancies with Rheumatic Diseases.” Clin Pharmacokinet 58, no. 4 (April 2019): 525–33. https://doi.org/10.1007/s40262-018-0712-z.
    Full Text Link to Item
  - Balevic, Stephen J., Michael Cohen-Wolkowiez, Amanda M. Eudy, Thomas P. Green, Laura E. Schanberg, and Megan E. B. Clowse. “Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes.” J Rheumatol 46, no. 1 (January 2019): 57–63. https://doi.org/10.3899/jrheum.180158.
    Full Text Link to Item
  - Balevic, Stephen J., and Michael Cohen-Wolkowiez. “Innovative Study Designs Optimizing Clinical Pharmacology Research in Infants and Children.” J Clin Pharmacol 58 Suppl 10 (October 2018): S58–72. https://doi.org/10.1002/jcph.1053.
    Full Text Link to Item
  - Wang, Laura A., P Brian Smith, Matthew Laughon, Ronald N. Goldberg, Lawrence C. Ku, Kanecia O. Zimmerman, Stephen Balevic, et al. “Prolonged furosemide exposure and risk of abnormal newborn hearing screen in premature infants.” Early Hum Dev 125 (October 2018): 26–30. https://doi.org/10.1016/j.earlhumdev.2018.08.009.
    Full Text Link to Item
  - Mater, Heather van, Stephen J. Balevic, Gary L. Freed, and Sarah J. Clark. “Prescribing for Children With Rheumatic Disease: Perceived Treatment Approaches Between Pediatric and Adult Rheumatologists.” Arthritis Care Res (Hoboken) 70, no. 2 (February 2018): 268–74. https://doi.org/10.1002/acr.23273.
    Full Text Link to Item
  - Sadun, Rebecca E., Melissa A. Wells, Stephen J. Balevic, Victoria Lackey, Erica J. Aldridge, Nicholas Holdgagte, Samya Mohammad, Lisa G. Criscione-Schreiber, Megan E. B. Clowse, and Mamata Yanamadala. “Increasing contraception use among women receiving teratogenic medications in a rheumatology clinic.” Bmj Open Qual 7, no. 3 (2018): e000269. https://doi.org/10.1136/bmjoq-2017-000269.
    Full Text Link to Item
  - Balevic, Stephen J., Mara L. Becker, Michael Cohen-Wolkowiez, and Laura E. Schanberg. “Clinical Trial Design in Juvenile Idiopathic Arthritis.” Paediatr Drugs 19, no. 5 (October 2017): 379–89. https://doi.org/10.1007/s40272-017-0244-2.
    Full Text Link to Item
  - Balevic, Stephen J., and Ankoor Shah. “Islands of Inflammation: Neurosarcoidosis.” Am J Med 130, no. 2 (February 2017): 157–60. https://doi.org/10.1016/j.amjmed.2016.09.009.
    Full Text Link to Item
  - Balevic, Stephen J., and C Egla Rabinovich. “Profile of adalimumab and its potential in the treatment of uveitis.” Drug Des Devel Ther 10 (2016): 2997–3003. https://doi.org/10.2147/DDDT.S94188.
    Full Text Link to Item
  - Balevic, Stephen, Michael Taylor, and Michelle Amaya. “Penile and scrotal swelling mimicking child abuse.” Clin Pediatr (Phila) 52, no. 10 (October 2013): 988–90. https://doi.org/10.1177/0009922813497826.
    Full Text Link to Item
- Conference Papers
  - Commander, S. J., D. Gonzalez, K. R. Kumar, T. Spears, M. Cohen-Wolkowiez, K. O. Zimmerman, S. J. Balevic, and C. P. Hornik. “The relationship between simulated milrinone exposure and hypotension in children.” In Cardiology in the Young, 2021. https://doi.org/10.1017/S1047951121003103.
    Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

In the News

Selected Grants

External Relationships

Selected Publications

Academic Articles

Conference Papers